These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

83 related items for PubMed ID: 2673462

  • 21. Autologous transplantation of chemotherapy-purged PBSC collections from high-risk leukemia patients: a pilot study.
    Lemoli RM, Visani G, Leopardi G, Motta MR, Rizzi S, Testoni N, Curti A, Tura S.
    Bone Marrow Transplant; 1999 Feb; 23(3):235-41. PubMed ID: 10084254
    [Abstract] [Full Text] [Related]

  • 22. Stem cells from peripheral blood and bone marrow: a comparative evaluation of the hemopoietic potential in the dog.
    Raghavachar A, Prümmer O, Fliedner TM, Calvo W, Steinbach IB.
    Int J Cell Cloning; 1983 Sep; 1(4):191-205. PubMed ID: 6366082
    [Abstract] [Full Text] [Related]

  • 23. CD34(+) hematopoietic progenitor cell selection of bone marrow grafts for autologous transplantation in pediatric patients.
    Kasow KA, Sims-Poston L, Eldridge P, Hale GA.
    Biol Blood Marrow Transplant; 2007 May; 13(5):608-14. PubMed ID: 17448921
    [Abstract] [Full Text] [Related]

  • 24. Difference in kinetics of hematopoietic reconstitution between ALL and ANLL after autologous bone marrow transplantation with marrow treated in vitro with mafosfamide (ASTA Z 7557).
    Douay L, Laporte JP, Mary JY, Lopez M, Lemonnier MP, Stachowiak J, Benitez O, Deloux J, Najman A, Salmon C.
    Bone Marrow Transplant; 1987 Jun; 2(1):33-43. PubMed ID: 3332155
    [Abstract] [Full Text] [Related]

  • 25. Optimizing the CD34+ and CD34+Thy-1+ stem cell content of peripheral blood collections.
    Stewart AK, Imrie K, Keating A, Anania S, Nayar R, Sutherland DR.
    Exp Hematol; 1995 Dec; 23(14):1619-27. PubMed ID: 8542956
    [Abstract] [Full Text] [Related]

  • 26. Factors influencing the haematological recovery after allogeneic bone marrow transplantation in leukaemia patients treated with methotrexate-containing GVHD prophylaxis: a single-centre experience.
    Hassan HT, Krog C, Stockschläder M, Schleimer B, Zeller W, Krüger W, Erttmann R, Zander AR.
    Anticancer Res; 1997 Dec; 17(1B):589-99. PubMed ID: 9066585
    [Abstract] [Full Text] [Related]

  • 27. Peripheral blood stem cell transplantation in young children: experience with harvesting, mobilization and engraftment.
    Kletzel M, Longino R, Rademaker AW, Danner-Koptik KE, Olszewski M, Morgan ER.
    Pediatr Transplant; 1998 Aug; 2(3):191-6. PubMed ID: 10084741
    [Abstract] [Full Text] [Related]

  • 28. Successful blood stem cell collection and transplant in children weighing less than 25 kg.
    Deméocq F, Kanold J, Chassagne J, Bezou MJ, Lutz P, deLumley L, Philip I, Vannier JP, Margueritte G, Lamagnére JP.
    Bone Marrow Transplant; 1994 Jan; 13(1):43-50. PubMed ID: 7912601
    [Abstract] [Full Text] [Related]

  • 29. Changes in granulocyte-monocyte colony-forming cells among leukocyte-interferon-treated chronic myelogenous leukemia patients.
    Talpaz M, Spitzer G, Hittelman W, Kantarjian H, Gutterman J.
    Exp Hematol; 1986 Aug; 14(7):668-71. PubMed ID: 3460811
    [Abstract] [Full Text] [Related]

  • 30. Peripheral blood stem cell transplantation as an alternative to autologous marrow transplantation in the treatment of acute myeloid leukemia?
    Vellenga E, van Putten WL, Boogaerts MA, Daenen SM, Verhoef GE, Hagenbeek A, Jonkhoff AR, Huijgens PC, Verdonck LF, van der Lelie J, Schouten HC, Gmür J, Wijermans P, Gratwohl A, Hess U, Fey MF, Löwenberg B.
    Bone Marrow Transplant; 1999 Jun; 23(12):1279-82. PubMed ID: 10414916
    [Abstract] [Full Text] [Related]

  • 31. Long-term engraftment failure after marrow ablation and autologous hematopoietic reconstitution: differences between peripheral blood stem cell and bone marrow recipients.
    Bentley SA, Brecher ME, Powell E, Serody JS, Wiley JM, Shea TC.
    Bone Marrow Transplant; 1997 Mar; 19(6):557-63. PubMed ID: 9085735
    [Abstract] [Full Text] [Related]

  • 32. Effects of progenitor cell dose and preleukapheresis use of human recombinant granulocyte colony-stimulating factor on the recovery of hematopoiesis after blood stem cell autografting in children.
    Kawano Y, Takaue Y, Watanabe T, Saito S, Abe T, Hirao A, Sato J, Ninomiya T, Suzue T, Koyama T.
    Exp Hematol; 1993 Jan; 21(1):103-8. PubMed ID: 7678082
    [Abstract] [Full Text] [Related]

  • 33. Very large amounts of peripheral blood progenitor cells eliminate severe thrombocytopenia after high-dose melphalan in advanced breast cancer patients.
    Benedetti G, Patoia L, Giglietti A, Alessio M, Pelicci P, Grignani F.
    Bone Marrow Transplant; 1999 Nov; 24(9):971-9. PubMed ID: 10556956
    [Abstract] [Full Text] [Related]

  • 34. G-CSF primed peripheral blood progenitor cells in autologous bone marrow transplantation: parameters affecting bone marrow engraftment.
    Bolwell BJ, Fishleder A, Andresen SW, Lichtin AE, Koo A, Yanssens T, Burwell R, Baucco P, Green R.
    Bone Marrow Transplant; 1993 Dec; 12(6):609-14. PubMed ID: 7511016
    [Abstract] [Full Text] [Related]

  • 35. Cell adhesion molecule expression on CD34+ cells in grafts and time to myeloid and platelet recovery after autologous stem cell transplantation.
    Watanabe T, Dave B, Heimann DG, Jackson JD, Kessinger A, Talmadge JE.
    Exp Hematol; 1998 Jan; 26(1):10-8. PubMed ID: 9430509
    [Abstract] [Full Text] [Related]

  • 36. [Favorable effect of hematopoietic stem cells isolated from blood on hematologic recovery following high-dosage chemotherapy].
    Richel DJ, Baars JW, Wijngaarden MJ, van der Schoot CE, Vlasveld LT, Rodenhuis S.
    Ned Tijdschr Geneeskd; 1993 Jan 30; 137(5):245-50. PubMed ID: 7679478
    [Abstract] [Full Text] [Related]

  • 37. Effects of recombinant human tumor necrosis factor on highly enriched hematopoietic progenitor cell populations from normal human bone marrow and peripheral blood and bone marrow from patients with chronic myeloid leukemia.
    Wisniewski D, Strife A, Atzpodien J, Clarkson BD.
    Cancer Res; 1987 Sep 15; 47(18):4788-94. PubMed ID: 3040231
    [Abstract] [Full Text] [Related]

  • 38. Progenitor cell numbers (CFU-GM, CFU-D, and CFU-Mix) and hemopoietic recovery following autologous marrow transplantation.
    Stewart FM, Kaiser DL, Ishitani KP, Pirsch GW, Niskanen E.
    Exp Hematol; 1989 Oct 15; 17(9):974-80. PubMed ID: 2673831
    [Abstract] [Full Text] [Related]

  • 39. Low numbers of megakaryocyte progenitors in grafts of cord blood cells may result in delayed platelet recovery after cord blood cell transplant.
    Kanamaru S, Kawano Y, Watanabe T, Nakagawa R, Suzuya H, Onishi T, Yamazaki J, Nakayama T, Kuroda Y, Takaue Y.
    Stem Cells; 2000 Oct 15; 18(3):190-5. PubMed ID: 10840072
    [Abstract] [Full Text] [Related]

  • 40. Factors influencing haemopoietic recovery following chemotherapy-mobilised autologous peripheral blood progenitor cell transplantation for haematological malignancies: a retrospective analysis of a 10-year single institution experience.
    Lowenthal RM, Fabères C, Marit G, Boiron JM, Cony-Makhoul P, Pigneux A, Agape P, Vezon G, Bouzgarou R, Dazey B, Fizet D, Bernard P, Lacombe F, Reiffers J.
    Bone Marrow Transplant; 1998 Oct 15; 22(8):763-70. PubMed ID: 9827973
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.